Good MorningEarnings from big tech were not enough to get the markets shooting higher on Friday. Blow-out reports from Apple and Google along with less-robust but still, better-than-expected reports from Facebook and Amazon failed to spark a major rally but the news is not all bad. Friday’s market action may have started off slow but by the end of the day, bullish momentum had the S&P 500 trading at the highs of the session.
The takeaway for investors and traders is this: the market did not want to be short going into the weekend. While not a guarantee of future results, it suggests a generally bullish attitude and an expectation the indices will begin moving higher in the coming days. The next major hurdle for the market will be next week's economic data. The key read will come on Friday with the non-farm payrolls report and there is a growing concern the labor markets have deteriorated over the last month.
Featured: Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) 
|
Stocks | | |
With the spot price of gold reaching new all-time highs of over $1,900 per ounce, it’s safe to say that the gold and precious metals market is heating up. Traditionally, gold is considered as a safe-haven asset or a hedge against the U.S. dollar, low-interest rates, and inflation. This could... Read the Full Story |
|
|
Markets | | | Sometimes with stocks, you’re better off not asking too many questions and just trusting your gut. From January 2017 to January 2018, shares of Paypal (NASDAQ: PYPL) ran up 120%. Since March of this year, they’re up about the same. For a $200 billion company, they sure know how to move a... Read the Full Story |
|
Markets | | | With a seven-year trading range of $200 to $400 and every price in between, shares of Massachusetts based Biogen (NASDAQ: BIIB) know exactly what it’s like to be a biotech company where your future depends on your next drug.
Shares are currently bobbing along in the middle of that range after... Read the Full Story |
|
From Our PartnersBehind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented.
And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots…
What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book. | | | Claim your FREE copy of Crypto Revolution now. |
|
Markets | | | That Was Then, This Is Now
There’s been growing speculation that tech, and specifically software, are in a bubble. The biggest comparison is the mad run-up to all-time highs set in the 1999/2000 time period but I have to say, that was then and this is now. Then, the market was speculating on ... Read the Full Story |
|
Markets | | | Juniper Networks (NYSE: JNPR) has been a favorite of mine over the last year for several reasons. Regarding its business, it is a maker of all-things networking-related and therefore fundamental to technology infrastructure. Read the Full Story |
|
From Our PartnersWashington is running out of money…And guess where they'll look next?
When governments go broke, they take from the people.
It's happened before, and it's happening again.
The Department of Justice just admitted that cash isn't legally YOUR property. | | | Get your free guide now by clicking here >> |
|
The Early Bird Stock Of The Day Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. | | View Today's Stock Pick |
|
